3rd Quarter - Report

LUNDBECK LLC for LUNDBECK LLC

Firm
Client
Income
—
Expenses
$170,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Step Therapy Reform - HR2279 & S.2546 The Safe Step Act

LobbyistCovered position, as disclosed
SALLY BENJAMIN YOUNG —
HEATHER STRAWN New —
REYNA TAYLOR New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2546 (116th), H.R. 2279 (116th)

Medicare/Medicaid MMM

The Excellence in Mental Health and Addiction Treatment Expansion Act (S. 824/ H.R. 1767) Medicare Part D Six Protected Classes Proposed Rule Medicare Part D Rebate Reform Proposed Rule STAR Act - H.R.2113 - Prescription drug transparency, accountability, and reporting FAIR Act - H.R. 2296 Fair accountability and innovative research in drug pricing REMEDY Act - S. 1209 Lower Drug Prices By Curbing Patent Manipulation, Promoting Generic Competition CREATES Act - H.R. 965 Promote access to samples and combine REMs programs for generics FAST Generics - H.R. 985 Promote access to samples and combine REMs programs for generics SPIKE Act - S. 474 Pharmaceutical Industry price increase reporting proposal Affordable Prescriptions for Patients Act - S. 1416 H.R. 1520 (Purple Book Continuity Act of 2019) H.R. 1503 (Orange Book Transparency Act of 2019) H.R. 3 S. 543

LobbyistCovered position, as disclosed
SALLY BENJAMIN YOUNG —
HEATHER STRAWN —
REYNA TAYLOR New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 474 (116th), H.R. 1503 (116th), H.R. 1520 (116th), H.R. 985 (116th), S. 824 (116th), H.R. 2296 (116th), S. 543 (116th), H.R. 2113 (116th), H.R. 965 (116th), S. 1209 (116th), H.R. 3 (116th), H.R. 1767 (116th), S. 1416 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.